Long-Term Outcome of Intact Abdominal Aortic Aneurysm After Endovascular or Open Repair

医学 围手术期 危险系数 腹主动脉瘤 腔内修复术 倾向得分匹配 外科 优势比 置信区间 回顾性队列研究 动脉瘤 队列 主动脉瘤 存活率 内科学
作者
Jasmin Epple,Yuliya Svidlova,Thomas Schmitz‐Rixen,Dittmar Böckler,Neelam Lingwal,Reinhart T. Grundmann
出处
期刊:Vascular and Endovascular Surgery [SAGE Publishing]
卷期号:57 (8): 829-837 被引量:3
标识
DOI:10.1177/15385744231178130
摘要

Endovascular aortic aneurysm repair (EVAR) has been established as a standard treatment option for intact abdominal aortic aneurysm (iAAA) and gained importance due to a lower perioperative mortality than open repair (OAR). However, whether this survival advantage can be maintained or if OAR is beneficial in terms of long-term complications and reinterventions remains questionable.In this retrospective cohort study data from patients undergoing elective EVAR or OAR for iAAAs in the years 2010-2016 was analyzed. The patients were followed through 2018.In the propensity score matched cohorts the perioperative and long-term outcomes of the patients were assessed. We identified 20 683 patients undergoing elective iAAA repair (76.4% EVAR). The propensity matched cohorts included 4886 pairs of patients.The perioperative mortality was 1.9% for EVAR and 5.9% for OAR (P = <.001). The perioperative mortality was mainly influenced by patients age (Odds-Ratio (OR):1.073, confidence interval (CI):1.058-1.088, P ≤ .001) and OAR (OR:3.242, CI:2.552-4.119, P ≤ .001). The early survival benefit after endovascular repair persisted for approximately 3 years (estimated survival EVAR 82.3%, OAR 80.9%, P = .021). After that time the estimated survival curves were similar. After 9 years the estimated survival was 51.2% after EVAR as compared to 52.8% after OAR (P = .102). The operation method didn't influence long-term survival significantly (Hazard-Ratio (HR): 1.046, CI: .975-1.122, P = .211). The vascular reintervention rate was 17.4% in the EVAR cohort and 7.1% in the OAR cohort (P ≤ .001).EVAR has a significantly lower perioperative mortality than OAR, a survival benefit that lasts up to 3 years after intervention. Thereafter, no significant difference in survival was observed between EVAR and OAR. The decision between EVAR or OAR may depend on patient preference, surgeons' experience, and the institutions' ability to handle complications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
times发布了新的文献求助10
刚刚
舒心的朝雪完成签到 ,获得积分10
1秒前
Lucas应助闪闪新梅采纳,获得10
1秒前
丘比特应助辰程程成采纳,获得10
1秒前
1秒前
张正发布了新的文献求助10
1秒前
研友_VZG7GZ应助pp采纳,获得10
2秒前
emmaguo713发布了新的文献求助10
2秒前
aa完成签到,获得积分10
2秒前
3秒前
3秒前
shiyongkang1完成签到,获得积分10
3秒前
超级铅笔完成签到,获得积分10
3秒前
海德堡完成签到,获得积分10
4秒前
科研通AI6.3应助蓝莓芝士采纳,获得10
5秒前
6秒前
追寻澜发布了新的文献求助20
6秒前
诚心酸奶完成签到,获得积分10
6秒前
不知为不知完成签到,获得积分10
6秒前
6秒前
超级铅笔发布了新的文献求助10
7秒前
JamesPei应助123采纳,获得10
7秒前
温暖的绮完成签到,获得积分10
8秒前
酷波er应助忧郁叫兽采纳,获得10
8秒前
银河唯一的秘密完成签到,获得积分10
8秒前
斯文败类应助冷静点格子采纳,获得10
9秒前
JINNA发布了新的文献求助10
9秒前
西窗雪完成签到,获得积分10
10秒前
科大第一深情完成签到,获得积分10
11秒前
YU完成签到,获得积分10
11秒前
Nxxxxxx发布了新的文献求助10
11秒前
11秒前
11秒前
张正完成签到,获得积分20
12秒前
脑洞疼应助许健采纳,获得10
13秒前
李佳笑完成签到,获得积分10
13秒前
chipmunk完成签到,获得积分10
14秒前
14秒前
谨慎鞅完成签到,获得积分10
14秒前
奥利奥完成签到,获得积分20
15秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
Organic Reactions, Volume 116 1000
Current concepts in cutaneous toxicity : proceedings of the Fourth Conference on Cutaneous Toxicity, Washington, D.C., May 9-11, 1979 1000
ズームレンズの光学設計に関する研究 800
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7277859
求助须知:如何正确求助?哪些是违规求助? 8898747
关于积分的说明 18819102
捐赠科研通 6950209
什么是DOI,文献DOI怎么找? 3206661
关于科研通互助平台的介绍 2377448
邀请新用户注册赠送积分活动 2181501